Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1
Prevalence and Risk Factors of HIV-associated Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 Infected Thai Individuals With Undetectable Viral Load in the HAART Era.
Sponsor: Chulalongkorn University
A observational or N/A phase clinical study on HIV Infections, this trial is completed. The trial is conducted by Chulalongkorn University and has accumulated 12 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Aug 2023 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Aug 2023 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Aug 2020 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Aug 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Mar 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chulalongkorn University
- SEARCH Research Foundation
- The HIV Netherlands Australia Thailand Research Collaboration
- University of Hawaii
- University of Missouri, Department of Psychology, Division of Neuroscience
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Bangkok, Thailand